EKF Diagnostics (LON:EKF) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened

EKF Diagnostics Holdings plc (LON:EKF)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 25.66 and traded as low as GBX 25.30. EKF Diagnostics shares last traded at GBX 25.41, with a volume of 99,145 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Stifel Nicolaus restated a “buy” rating and set a GBX 35 price objective on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Price Performance

The company has a 50 day moving average price of GBX 26.26 and a 200-day moving average price of GBX 25.66. The company has a market cap of £109.32 million, a price-to-earnings ratio of 54.06 and a beta of 0.51. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.